載入...
Comparison of outcomes of HCT in blast phase of BCR-ABL1(−) MPN with de novo AML and with AML following MDS
Comparative outcomes of allogeneic hematopoietic cell transplantation (HCT) for BCR-ABL1(−) myeloproliferative neoplasms (MPNs) in blast phase (MPN-BP) vs de novo acute myeloid leukemia (AML), and AML with prior myelodysplastic syndromes (MDSs; post-MDS AML), are unknown. Using the Center for Intern...
Na minha lista:
| 發表在: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7556156/ https://ncbi.nlm.nih.gov/pubmed/33007075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002621 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|